Research Site

Huddinge 14157

5 studies enrolling now · 7 studies all time

What they study most

Cardiovascular Disease, Chronic Kidney Disease and Hypertension, Heart Failure, Idiopathic Inflammatory Myopathies, Pulmonary Hypertension (World Health Organization Group 2), Rheumatoid Arthritis, Systemic Sclerosis, Thrombotic Microangiopathy, Viral Lung Infection and Acute Respiratory Failure

Studies at this site

• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin — Recruiting now
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure — Recruiting now
• A Study of AZD0120 in Autoimmune Diseases — Recruiting now
• Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen — Recruiting now
• A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event — Recruiting now
• Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant — Completed
• A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2 — Completed